Polish archives of internal medicine · 2026
Patient perspective on the management of hypertension in 7 European countries: insights from a survey of 4001 patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Burnier Michel, Prejbisz Aleksander, Vaclavik Jan, Gupta Pankaj, Azizi Michel, Dobrowolski Piotr, Niro-Martin Sandra, Cunha Vitoria, Versmissen Jorie, Magne Julien, Desideri Giovambattista, Persu Alexandre, Working Group on Lifestyle, Cardiovascular Pharmacotherapy, and Adherence of the European Society of Hypertension
Аннотация
INTRODUCTION: Few studies have assessed patient perception of the management of their hypertension in Europe.
OBJECTIVES: We aimed to compare the attitudes, barriers, and expectations of patients receiving treatment for hypertension in 7 European countries.
PATIENTS AND METHODS: Cross‑sectional data were obtained between January and April 2023, using a web‑based questionnaire translated into each country's official language and distributed in the Czech Republic, France, Germany, Italy, Poland, Spain, and the United Kingdom (UK). A total of 4001 treated hypertensive adults returned a valid questionnaire. Their mean (SD) age was 68.3 (9.2) years (median, 70 y), 59.7% were men, and 91% were treated for longer than 1 year.
RESULTS: The participants from Poland and the Czech Republic had a more unfavorable cardiovascular risk profile than those from other countries (P <0.001). Differences across the countries were found for lifestyle, medical, and emotional risk scores (P <0.001). A total median number of pills per day was 4 (range, 3-5/d; P <0.001 between countries) and 2 for antihypertensive drugs. The frequency of follow‑up visits per year was the highest in France and lowest in the UK (P <0.001). In all countries, 10%-20% of the participants expressed a wish for more information mainly on treatment, drug side effects, and hypertension complications. Nonintentional interruption of medications was the main cause of nonadherence.
CONCLUSIONS: According to patients, the management of hypertension is highly variable in different European countries. Our survey identified features that could be improved, such as increasing the amount of information provided to the patients, empowering the patients through adequate home blood pressure monitoring, and supporting medication adherence.
OBJECTIVES: We aimed to compare the attitudes, barriers, and expectations of patients receiving treatment for hypertension in 7 European countries.
PATIENTS AND METHODS: Cross‑sectional data were obtained between January and April 2023, using a web‑based questionnaire translated into each country's official language and distributed in the Czech Republic, France, Germany, Italy, Poland, Spain, and the United Kingdom (UK). A total of 4001 treated hypertensive adults returned a valid questionnaire. Their mean (SD) age was 68.3 (9.2) years (median, 70 y), 59.7% were men, and 91% were treated for longer than 1 year.
RESULTS: The participants from Poland and the Czech Republic had a more unfavorable cardiovascular risk profile than those from other countries (P <0.001). Differences across the countries were found for lifestyle, medical, and emotional risk scores (P <0.001). A total median number of pills per day was 4 (range, 3-5/d; P <0.001 between countries) and 2 for antihypertensive drugs. The frequency of follow‑up visits per year was the highest in France and lowest in the UK (P <0.001). In all countries, 10%-20% of the participants expressed a wish for more information mainly on treatment, drug side effects, and hypertension complications. Nonintentional interruption of medications was the main cause of nonadherence.
CONCLUSIONS: According to patients, the management of hypertension is highly variable in different European countries. Our survey identified features that could be improved, such as increasing the amount of information provided to the patients, empowering the patients through adequate home blood pressure monitoring, and supporting medication adherence.